COMMUNIQUÉS West-GlobeNewswire

Adventist Health Receives “A” Rating; Positive Outlook From Fitch Ratings

05/02/2018 - 20:18

ROSEVILLE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—is pleased to announce it has [...]

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017

05/02/2018 - 19:11

Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017 Curetis subsidiary Ares Genetics receives funding commitment from Austrian [...]

LIPSG Announces Two Major Appointments: Tommaso Addona, MD, FACS, appointed Chief of Plastic Surgery at St. Joseph Hospital, Bethpage Jerry W. Chang, MD, appointed Chief of Plastic Surgery at NewYork-Presbyterian Queens

05/02/2018 - 19:00

GARDEN CITY, NY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group in Garden City is pleased to announce that two LIPSG surgeons were recently appointed Chief of Plastic Surgery at area hospitals. [...]

AspireAssist® Demonstrates Significant Weight Loss through Four Years with Strong Safety Profile

05/02/2018 - 18:15

KING OF PRUSSIA, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company, announced today the publication of 201-patient, multi-center post-market European registry [...]

Sanofi: Disclosure of trading in own shares

05/02/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/ce99ad50-5d59-4896-8726-188fc74e598c

Sanofi : Déclaration des transactions sur actions propres

05/02/2018 - 17:46

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/5d94669a-e3c0-4d93-b256-600b9ce513b7

Nymox Announces US NDA for Fexapotide for BPH

05/02/2018 - 17:15

HASBROUCK HEIGHTS, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) announced today that the Company will submit a New Drug Application (NDA) for Fexapotide Triflutate for the [...]

Capricor Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Duchenne Muscular Dystrophy Therapy

05/02/2018 - 17:11

LOS ANGELES, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002, its lead investigational cell therapy for the [...]

Ossur Hf : Transactions in relation to share buyback program

05/02/2018 - 17:01

Announcement from Össur hf. No. 7/2018 Reykjavík, 05 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Agility Health Announces Definitive Agreement to sell U.S.-Based Operations

05/02/2018 - 15:10

GRAND RAPIDS, Mich., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility Health” or the “Company”) announced today that it has signed a definitive agreement (the “Purchase Agreement”) to sell 100 [...]

CareDx Leadership in cfDNA Highlighted at CEoT

05/02/2018 - 15:00

BRISBANE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value [...]

United Health Products Announces Completion of FDA PMA for HemoStyp®

05/02/2018 - 15:00

HENDERSON, Nev., Feb. 05, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC) today announced that, following its January 17 face-to- face meeting with FDA experts and officials, it has completed and [...]

The Ensign Group Acquires Two Texas Assisted Living Facilities

05/02/2018 - 15:00

MISSION VIEJO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]

The Ensign Group Schedules Year-End 2017 Earnings Call for Friday, February 9, 2018

05/02/2018 - 15:00

MISSION VIEJO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, assisted living, home health, [...]

REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors

05/02/2018 - 15:00

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the appointment of Stephen [...]

Rapid Micro Biosystems announces New Vice President of Operations

05/02/2018 - 15:00

LOWELL, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Mike Noyes as Vice President [...]

PolarityTE™ Provides Business Updates on Clinical Use of SkinTE™: Regeneration of Full-Thickness Skin

05/02/2018 - 15:00

SALT LAKE CITY, Feb. 05, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ), today announced that initial results from the clinical applications of the commercially launched SkinTE are yielding outcomes that are [...]

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

05/02/2018 - 14:45

PLYMOUTH MEETING, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that the Company will participate in the following upcoming investment conferences: BIO CEO & [...]

OncBioMune Signs Letter of Intent to Initiate Phase 2 Trial of ProscaVax for Advanced Prostate Cancer with Urology Clinics of North Texas

05/02/2018 - 14:45

BATON ROUGE, La., Feb. 05, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]